Related Experiment Videos
Managing the neuropsychiatric adverse effects of interferon treatment
1Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. avalenti@notes.mdacc.tmc.edu
Abstract:
Patients who receive interferons are vulnerable to a wide variety of neuropsychiatric adverse effects which can seriously compromise otherwise effective therapy. The nature and severity of the adverse effects are, in part, dose dependent, though there is significant variability. Effective treatment of interferon adverse effects is hindered by the absence of an identified mechanism of toxicity and lack of controlled intervention trials. Successful management of adverse effects is facilitated by a multimodal approach, starting with pre-treatment screening and discussion. Behavioural techniques help maintain daily function. Dose reduction or drug holidays may be required. Pharmacological treatment is based largely on clinical experience, though formal studies are underway. Familiarity with several classes of psychotropic medications is required, including antidepressants, anxiolytics, antipsychotics and psychostimulants. Together, these interventions may be used to reduce severity of interferon behavioural adverse effects to tolerable levels.
Insights
Interferon therapy can cause significant neuropsychiatric side effects. A multimodal approach, including behavioral techniques and psychotropic medications, helps manage these adverse effects.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Interferon therapy is associated with diverse neuropsychiatric adverse effects.
- These effects can compromise treatment efficacy and patient quality of life.
- Adverse effect severity is partly dose-dependent but shows significant variability.
Purpose of the Study:
- To review the management strategies for interferon-induced neuropsychiatric adverse effects.
- To highlight the need for a multimodal approach in managing these side effects.
Main Methods:
- Literature review focusing on clinical experience and ongoing studies.
- Discussion of pre-treatment screening, behavioral interventions, dose adjustments, and pharmacological treatments.
Main Results:
- Effective management requires a multimodal strategy.
- Behavioral techniques aid daily functioning.
- Pharmacological options include antidepressants, anxiolytics, antipsychotics, and psychostimulants.
Conclusions:
- A comprehensive approach is crucial for managing interferon-induced neuropsychiatric adverse effects.
- Interventions can reduce side effect severity to tolerable levels.
- Further controlled trials are needed to establish optimal treatment mechanisms.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Psychosis: Goals of Pharmacotherapy
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug Therapy
Antianxiety Medications
Alzheimer's Disease: Treatment